论文信息 - Catheter Lock and Systemic Infusion of Linezolid for Treatment of Persistent Broviac Catheter-Related Staphylococcal Bacteremia

Catheter Lock and Systemic Infusion of Linezolid for Treatment of Persistent Broviac Catheter-Related Staphylococcal Bacteremia

The treatment of persistently positive blood cultures in the setting of indwelling central venous catheter (CVC)-related bacteremia may represent a difficult task when CVC removal is not feasible. In this setting, antibiotic lock has been demonstrated to be an effective option, both as a first-line

[1] M. Provinciali,et al. Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.

[2] W. Peetermans,et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. , 2005, The Journal of antimicrobial chemotherapy.

[3] M. Cormican,et al. Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections , 2003, Antimicrobial Agents and Chemotherapy.

[4] D. Stalker,et al. Clinical Pharmacokinetics of Linezolid, a Novel Oxazolidinone Antibacterial , 2003, Clinical pharmacokinetics.

[5] L. Mermel,et al. Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.

[6] R. Feigin,et al. Textbook of Pediatric Infectious Diseases , 1986 .